Understanding Treatment Preferences for Patients with Tricuspid Regurgitation.
Vijay IyerNadeen N FazaMichael PfeifferMark KozakBrandon PetersonMortiz Wyler von BallmoosSarah MollenkopfMelissa MancillaDiandra Latibeaudiere-GardnerMichael J ReardonPublished in: MDM policy & practice (2024)
This study provides quantitative patient preference data from clinically confirmed tricuspid regurgitation (TR) patients to understand their treatment preferences.Using a targeted literature search and patient, physician, and Food and Drug Administration feedback, a cross-sectional survey with a discrete-choice experiment that focused on 5 of the most important attributes to TR patients was developed and administered online.TR patients are willing to accept higher procedural reintervention risk if shortness of breath is alleviated, and this risk tolerance is higher for older and more symptomatic patients.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- systematic review
- peritoneal dialysis
- emergency department
- primary care
- prognostic factors
- aortic valve
- heart failure
- drug delivery
- risk assessment
- climate change
- electronic health record
- machine learning
- atrial fibrillation
- patient reported
- replacement therapy
- human health
- data analysis